ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 学術雑誌論文

Developmen Validation of a Novel Four Gene-Pairs Signature for Predicting Prognosis in DLBCL Patients

https://az.repo.nii.ac.jp/records/2000238
https://az.repo.nii.ac.jp/records/2000238
8ab72ab5-be7e-4fcb-8792-496b26af13d9
名前 / ファイル ライセンス アクション
ijms-25-12807-v2 ijms-25-12807-v2 (1).pdf (5 MB)
Item type 学術雑誌論文 / Journal Article(1)
公開日 2024-12-24
タイトル
タイトル Developmen Validation of a Novel Four Gene-Pairs Signature for Predicting Prognosis in DLBCL Patients
言語 en
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
著者 Tanabe, Atsushi

× Tanabe, Atsushi

en Tanabe, Atsushi

Search repository
Ndzinu, Jerry

× Ndzinu, Jerry

en Ndzinu, Jerry

Search repository
Sahara, Hiroeki

× Sahara, Hiroeki

en Sahara, Hiroeki

Search repository
Abstract
内容記述タイプ Abstract
内容記述 Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin’s lymphoma. Because individual clinical outcomes of DLBCL in response to standard therapy differ widely, new treatment strategies are being investigated to improve therapeutic efficacy. In this study, we identified a novel signature for stratification of DLBCL useful for prognosis prediction and treatment selection. First, 408 prognostic gene sets were selected from approximately 2500 DLBCL samples in public databases, from which four gene-pair signatures consisting of seven prognostic genes were identified by Cox regression analysis. Then, the risk score was calculated based on these gene-pairs and we validated the risk score as a prognostic predictor for DLBCL patient outcomes. This risk score demonstrated independent predictive performance even when combined with other clinical parameters and molecular subtypes. Evaluating external DLBCL cohorts, we demonstrated that the risk-scoring model based the four gene-pair signatures leads to stable predictive performance, compared with nine existing predictive models. Finally, high-risk DLBCL showed high resistance to DNA damage caused by anticancer drugs, suggesting that this characteristic is responsible for the unfavorable prognosis of high-risk DLBCL patients. These results provide a novel index for classifying the biological characteristics of DLBCL and clearly indicate the importance of genetic analyses in the treatment of DLBCL
言語 en
書誌情報 International Journal of Molecular Sciences

巻 25, 号 23, p. 1-17, 発行日 2024-11
出版者
出版者 MDPI
DOI
識別子タイプ DOI
関連識別子 10.3390/ijms252312807
著者版フラグ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
査読
内容記述タイプ Other
内容記述 査読あり
戻る
0
views
See details
Views

Versions

Ver.1 2024-12-18 02:02:36.028117
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3